26 results
DEFM14A
SQZB
SQZ Biotechnologies Co
23 Jan 24
Proxy related to merger
4:31pm
immunotherapy, (ii) the 2018 Roche Agreement and 2017 Roche Agreement were not negotiated together as a package with a single commercial objective and (iii
PREM14A
SQZB
SQZ Biotechnologies Co
12 Jan 24
Preliminary proxy related to merger
8:57am
targets in cancer immunotherapy, (ii) the 2018 Roche Agreement and 2017 Roche Agreement were not negotiated together as a package with a single
DEFA14A
SQZB
SQZ Biotechnologies Co
26 Apr 23
Additional proxy soliciting materials
4:31pm
. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year's meeting, you must make this request
PRE 14A
SQZB
SQZ Biotechnologies Co
10 Apr 23
Preliminary proxy
4:31pm
compensation package and further incentivizes our employees, including our named executive officers, in accordance with our compensation policies
DEFA14A
2likjuw 7738gd7sn3v
26 Apr 22
Additional proxy soliciting materials
5:08pm
8-K
EX-99.2
qy9sqjiob g9
4 Jun 21
Regulation FD Disclosure
8:09am
DEFA14A
8g2mf445rwq1ma 4giq
26 Apr 21
Additional proxy soliciting materials
5:10pm
DEF 14A
9xvv29 9tpnq9
26 Apr 21
Definitive proxy
5:00pm
10-K
nt8k4fuydk0e5bbkoq0d
18 Mar 21
Annual report
6:31am
424B4
hcvej1453
12 Feb 21
Prospectus supplement with pricing info
5:10pm
DRS
9vi54u
1 Feb 21
Draft registration statement
12:00am
10-Q
c9o5k7nbh7vwwqw wp
10 Dec 20
Quarterly report
4:46pm
424B4
9koz bmrmng
30 Oct 20
Prospectus supplement with pricing info
4:54pm